搜索临床试验以:neoadjuvant trastuzumab
总计4388个结果
-
Albert Einstein College of MedicineMerck Sharp & Dohme LLC完全的
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.终止
-
Hebei Medical University未知
-
Ruijin HospitalJiangsu HengRui Medicine Co., Ltd.未知乳腺癌 | HER2阳性乳腺癌 | ER阳性乳腺癌
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research Group完全的
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Osaka Medical College终止乳腺癌 | HER-2阳性乳腺癌 | 雌激素受体阴性肿瘤日本
-
Hoffmann-La Roche完全的
-
Shandong University未知
-
Pfizer完全的早期乳腺癌捷克语, 塞尔维亚, 斯洛伐克, 美国, 白俄罗斯, 匈牙利, 乌克兰, 意大利, 波兰, 俄罗斯联邦
-
SOLTI Breast Cancer Research GroupNovartis完全的
-
Institute of Cancer Research, United KingdomNovartis; Cancer Research UK; Manchester University NHS Foundation Trust; University of Manchester主动,不招人
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio State University... 和其他合作者完全的
-
University of Kansas Medical CenterCelgene Corporation完全的
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Severance Hospital未知
-
George Albert FisherSanofi; GlaxoSmithKline完全的
-
SOLTI Breast Cancer Research Group完全的
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor Pharma完全的炎性乳腺癌 | HER2阳性乳腺癌 | 管状乳腺癌 II 期 | 粘液性乳腺癌 II 期 | 乳腺癌女性 NOS | 浸润性导管癌 | 管状乳腺癌 III 期德国
-
Unity Health TorontoHoffmann-La Roche未知
-
Translational Research Center for Medical Innovation...完全的
-
Jenny C. Chang, MDGenentech, Inc.; The Methodist Hospital Research Institute撤销
-
European Organisation for Research and Treatment...GlaxoSmithKline完全的
-
NSABP Foundation IncGlaxoSmithKline未知
-
GlaxoSmithKline完全的
-
German Breast GroupAGO Study Group完全的
-
King Faisal Specialist Hospital & Research Center完全的
-
Hospital Affiliated to Military Medical Science...未知